Fate Therapeutics (FATE) PT Lowered to $71 at Piper Sandler
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.57 +1.98%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff lowered the price target on Fate Therapeutics (NASDAQ: FATE) to $71.00 (from $113.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fate Therapeutics (FATE) PT Raised to $3.50 at Wells Fargo
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
